Dawes Fretzin Clinical Research Group

Recent papers from Dawes Fretzin Clinical Research Group

1. Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled studyJournal of the American Academy of Dermatology · 2025
2. Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With PsoriasisJAMA Dermatology · 2024
3. Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)JAMA Dermatology · 2022
4. Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasisBritish Journal of Dermatology · 2018
5. Patients’ Perspectives on the Impact of Genital Psoriasis: A Qualitative StudyDermatology and Therapy · 2017
6. Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasisJournal of Dermatological Treatment · 2016